Raynaud phenomenon and digital ulcers in systemic sclerosis
Top Cited Papers
- 25 February 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 16 (4), 208-221
- https://doi.org/10.1038/s41584-020-0386-4
Abstract
Raynaud phenomenon is a symptom complex caused by impaired digital perfusion and can occur as a primary phenomenon or secondary to a wide range of underlying causes. Raynaud phenomenon occurs in virtually all patients with systemic sclerosis (SSc) and is often the earliest clinical manifestation to occur. Careful assessment is required in patients with Raynaud phenomenon to avoid missing secondary causes such as SSc. Digital ulcers are a painful and disabling visible manifestation of digital vascular injury in patients with SSc. Progress has been made in the classification and assessment of digital ulcers and in understanding ulcer pathogenesis, and there are a wide range of treatments available to both prevent and heal digital ulcers, some of which are also used in Raynaud phenomenon management. In this Review, the assessment of patients with Raynaud phenomenon is discussed, including ‘red flags’ that are suggestive of SSc. The pathogenesis, classification and assessment of SSc-associated digital ulcers are also covered, alongside an overview of management approaches for SSc-associated Raynaud phenomenon and digital ulcers. Finally, unmet needs are discussed and the concept of a unified vascular phenotype in which therapies that affect the vasculature to support disease modification strategies is introduced.Keywords
This publication has 140 references indexed in Scilit:
- Meta‐Analysis of Healing and Prevention of Digital Ulcers in Systemic SclerosisArthritis Care & Research, 2013
- Scleroderma digital ulcers complicated by infection with fecal pathogensArthritis Care & Research, 2011
- Atherosclerosis in systemic sclerosis: A systematic review and meta-analysisArthritis & Rheumatism, 2011
- Imatinib treatment of generalized localized scleroderma (morphea)Journal of the American Academy of Dermatology, 2010
- Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialAnnals Of The Rheumatic Diseases, 2010
- The treatment with N-acetylcysteine of Raynaud’s phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patientsClinical Rheumatology, 2009
- A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprostClinical Rheumatology, 2009
- Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisAnnals Of The Rheumatic Diseases, 2009
- Impact of digital ulcers on disability and health-related quality of life in systemic sclerosisAnnals Of The Rheumatic Diseases, 2009
- Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma)Clinical Rheumatology, 2005